|
|
Vaccine Comparison
|
DT Polio Adsorbed |
| Vaccine Information |
- Vaccine Name: DT Polio Adsorbed
- Tradename: DT Polio Adsorbed
- Manufacturer: Sanofi Pasteur Ltd
- Vaccine Ontology ID: VO_0010709
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- VO ID: VO_0000128
- Description: Products: Proteins + killed virus. Other components: Formaldehyde.
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin
- Immunization Route: Intramuscular injection (i.m.)
- Approved Age for Licensed Use: Ages 7 and older.
- Description: Products: Proteins + killed virus. Other components: Formaldehyde.
|
| References |
|
|
|
Infanrix -IPV/Hib |
| Vaccine Information |
- Vaccine Name: Infanrix -IPV/Hib
- Product Name: Diphtheria, tetanus, pertussis (acellular component), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed)
- Tradename: Infanrix -IPV/Hib
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010722
- CDC CVX code: 120
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin , Latex in plunger stopper of prefilled syringe
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store in a refrigerator (2°C – 8°C).
- Approved Age for Licensed Use: 2 months to 6 years of age.
- Description: Products: Proteins + killed virus + conjugate. Other components: Formaldehyde Polysorbate 80, Lactose.
|
| References |
|
|
|
Infanrix -IPV/Hib |
| Vaccine Information |
- Vaccine Name: Infanrix -IPV/Hib
- Tradename: Infanrix -IPV/Hib
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010722
- CDC CVX code: 120
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin , Latex in plunger stopper of prefilled syringe
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store in a refrigerator (2°C – 8°C).
- Approved Age for Licensed Use: 2 months to 6 years of age.
- Description: Products: Proteins + killed virus + conjugate. Other components: Formaldehyde Polysorbate 80, Lactose.
|
| References |
|
|
|
Infanrix-hexa |
| Vaccine Information |
- Vaccine Name: Infanrix-hexa
- Product Name: Combined diphtheria and tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b vaccine
- Tradename: Infanrix-hexa
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010719
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin, Latex in plunger stopper of prefilled syringe
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Should be stored at 2° to 8°C (35° to 46°F).
- Approved Age for Licensed Use: Under 7 years of age.
- Description: Products: Proteins + killed viruses + conjugate. Other components: Yeast protein Formaldehyde, Lactose, Polysorbate 20 and 80.
|
| References |
|
|
|
Infanrix-hexa |
| Vaccine Information |
- Vaccine Name: Infanrix-hexa
- Product Name: Combined diphtheria and tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b vaccine
- Tradename: Infanrix-hexa
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010719
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin, Latex in plunger stopper of prefilled syringe
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Should be stored at 2° to 8°C (35° to 46°F).
- Approved Age for Licensed Use: Under 7 years of age
- Description: Products: Proteins + killed viruses + conjugate. Other components: Yeast protein Formaldehyde, Lactose, Polysorbate 20 and 80.
|
| References |
|
|
|
Infanrix-IPV |
| Vaccine Information |
- Vaccine Name: Infanrix-IPV
- Product Name: Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)
- Tradename: Infanrix-IPV
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010721
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin , Latex in plunger stopper of prefilled syringes
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store in a refrigerator (2°C - 8°C).
- Approved Age for Licensed Use: 2 months to 6 years of age.
- Description: Products: Proteins + killed virus. Other components: Formaldehyde, Polysorbate 80.
|
| References |
|
|
|
Infanrix-IPV |
| Vaccine Information |
- Vaccine Name: Infanrix-IPV
- Tradename: Infanrix-IPV
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010721
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin , Latex in plunger stopper of prefilled syringes
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store in a refrigerator (2°C - 8°C).
- Approved Age for Licensed Use: 2 months to 6 years of age.
- Description: Products: Proteins + killed virus. Other components: Formaldehyde, Polysorbate 80.
|
| References |
|
|
|
Infanrix/Hib |
| Vaccine Information |
- Vaccine Name: Infanrix/Hib
- Tradename: Infanrix/Hib
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010720
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- VO ID: VO_0000127
- Description: Products: Proteins + conjugate. Other components: Formaldehyde, Lactose.
- Preservative: 2 phenoxy ethanol
- Allergen: Latex in plunger stopper of prefilled syringe
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2°C – 8°C (in a refrigerator).
- Approved Age for Licensed Use: 15 months and older
- Description: Products: Proteins + conjugate. Other components: Formaldehyde, Lactose.
|
| References |
|
|
|
Pediacel |
| Vaccine Information |
- Vaccine Name: Pediacel
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine and Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate)
- Tradename: Pediacel
- Manufacturer: Sanofi Pasteur Ltd
- Vaccine Ontology ID: VO_0010730
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Neomycin Polymyxin B Streptomycin, Latex in stopper of vial
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F).
- Approved Age for Licensed Use: 2 months to 6 years of age.
- Description: Products: Proteins, killed virus + conjugate. Other components: Bovine serum Formaldehyde, Polysorbate 80.
|
| References |
|
|
|
Pediacel |
| Vaccine Information |
- Vaccine Name: Pediacel
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine and Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate)
- Tradename: Pediacel
- Manufacturer: Sanofi Pasteur Ltd
- Vaccine Ontology ID: VO_0010730
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- VO ID: VO_0000128
- Description: Products: Proteins, killed virus + conjugate. Other components: Bovine serum Formaldehyde, Polysorbate 80.
- Preservative: 2 phenoxy ethanol
- Allergen: Neomycin Polymyxin B Streptomycin, Latex in stopper of vial
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F).
- Approved Age for Licensed Use: 2 months to 6 years of age.
- Description: Products: Proteins, killed virus + conjugate. Other components: Bovine serum Formaldehyde, Polysorbate 80.
|
| References |
|
|
|
Pediarix |
| Vaccine Information |
- Vaccine Name: Pediarix
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined
- Tradename: Pediarix
- Manufacturer: GlaxoSmithKline Biologicals
- Vaccine Ontology ID: VO_0000082
- CDC CVX code: 110
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: USA (License #1617)
- Host Species for Licensed Use: Human
- Adjuvant:
- VO ID: VO_0000127
- Description: The vaccine contains diphtheria and tetanus toxoids, 3 pertussis antigens (inactivated pertussis toxin [PT] and formaldehyde-treated filamentous hemagglutinin [FHA] and pertactin [69 kiloDalton outer membrane protein]), hepatitis B surface antigen, plus poliovirus Type 1 (Mahoney), Type 2 (MEF-1), and Type 3 (Saukett) (FDA: Pediarix).
- Allergen: Polymyxin B Neomycin, Latex in plunger stopper of prefilled syringe
- Preparation: Tetanus toxin is produced by growing Clostridium tetani in a modified Latham medium derived from bovine casein. The toxin is then detoxified with formaldehyde, concentrated by ultrafiltration, and purified by precipitation, dialysis, and sterile filtration (FDA: Pediarix).
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store PEDIARIX refrigerated between 2º and 8ºC (36º and 46ºF). Do not freeze.
- Approved Age for Licensed Use: PEDIARIX is indicated for active immunization against diphtheria, tetanus, pertussis (whooping cough), all known subtypes of hepatitis B virus, and poliomyelitis caused by poliovirus Types 1, 2, and 3 as a three-dose primary series in infants born of HBsAg-negative mothers, beginning as early as 6 weeks of age. PEDIARIX should not be administered to any infant before the age of 6 weeks, or to individuals 7 years of age or older (FDA: Pediarix).
- Contraindication: Hypersensitivity to any component of the vaccine, including yeast, neomycin, and polymyxin B, is a contraindication. The vaccine should not be administered to anyone with a previous alergic reaction following a dose of the vaccine, or if they have encephalopathy or a progressive neurologic disorder (FDA: Pediarix).
- Description: The vaccine contains diphtheria and tetanus toxoids, 3 pertussis antigens (inactivated pertussis toxin [PT] and formaldehyde-treated filamentous hemagglutinin [FHA] and pertactin [69 kiloDalton outer membrane protein]), hepatitis B surface antigen, plus poliovirus Type 1 (Mahoney), Type 2 (MEF-1), and Type 3 (Saukett) (FDA: Pediarix).
|
| References |
FDA: Pediarix: FDA: Pediarix [http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm146759.htm]
|
|
Pentacel |
| Vaccine Information |
- Vaccine Name: Pentacel
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine
- Tradename: Pentacel
- Manufacturer: Sanofi Pasteur Limited
- Vaccine Ontology ID: VO_0000084
- CDC CVX code: 120
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: USA (License #1726), Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- VO ID: VO_0000128
- Description: It consists of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component. Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b (FDA: Pentacel).
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B, Neomycin
- Preparation: Corynebacterium diphtheriae is grown in modified Mueller’s growth medium. After purification by ammonium sulfate fractionation, the diphtheria toxin is detoxified with formaldehyde and diafiltered. (FDA: Pentacel).
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F). Do not freeze.
- Approved Age for Licensed Use: 6 weeks to 4 years of age.
- Contraindication: A severe allergic reaction (e.g., anaphylaxis) after a previous dose of Pentacel vaccine, any ingredient of this vaccine, or any other tetanus toxoid, diphtheria toxoid, pertussis-containing vaccine, inactivated poliovirus vaccine or H influenzae type b vaccine is a contraindication. (FDA: Pentacel).
- Description: It consists of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component. Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b (FDA: Pentacel).
|
| References |
FDA: Pentacel: FDA: Pentacel Vaccine [https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109810.pdf]
|
|
Pentacel |
| Vaccine Information |
- Vaccine Name: Pentacel
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine
- Tradename: Pentacel
- Manufacturer: Sanofi Pasteur Limited
- Vaccine Ontology ID: VO_0000084
- CDC CVX code: 120
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: USA (License #1726), Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- VO ID: VO_0000128
- Description: It consists of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component. Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b. Pentacel vaccine is approved for use in children 6 weeks through 4 years of age (prior to fifth birthday) (FDA: Pentacel).
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B, Neomycin
- Preparation: Clostridium tetani is grown in modified Mueller-Miller casamino acid medium. Tetanus toxin is detoxified with formaldehyde and purified by ammonium sulfate fractionation and diafiltration. Diphtheria and tetanus toxoids are individually adsorbed onto aluminum phosphate (FDA: Pentacel).
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F). Do not freeze
- Approved Age for Licensed Use: Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b. Pentacel vaccine is approved for use in children 6 weeks through 4 years of age (prior to fifth birthday) (FDA: Pentacel).
- Contraindication: A severe allergic reaction (e.g., anaphylaxis) after a previous dose of Pentacel vaccine, any ingredient of this vaccine, or any other tetanus toxoid, diphtheria toxoid, pertussis-containing vaccine, inactivated poliovirus vaccine or H influenzae type b vaccine is a contraindication. The vaccine should also not be administered to anyone with known encephalopathy or a progressive neurologic disorder (FDA: Pentacel).
- Description: It consists of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component. Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b. Pentacel vaccine is approved for use in children 6 weeks through 4 years of age (prior to fifth birthday) (FDA: Pentacel).
|
| References |
FDA: Pentacel: FDA: Pentacel Vaccine [https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109810.pdf]
|
|
Quadracel |
| Vaccine Information |
- Vaccine Name: Quadracel
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine
- Tradename: Quadracel
- Manufacturer: Sanofi Pasteur Ltd
- Vaccine Ontology ID: VO_0010736
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B, Neomycin
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2 to 8C (35 to 46F). Do not freeze.
- Approved Age for Licensed Use: 2 months to six years of age.
- Description: Products: Proteins + killed virus. Other components: Bovine albumin Formaldehyde, Glutaraldehyde, Polysorbate 80.
|
| References |
|
|
|
Quadracel |
| Vaccine Information |
- Vaccine Name: Quadracel
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine
- Tradename: Quadracel
- Manufacturer: Sanofi Pasteur Ltd
- Vaccine Ontology ID: VO_0010736
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- VO ID: VO_0000128
- Description: Description: Products: Proteins + killed virus. Other components: Bovine albumin Formaldehyde, Glutaraldehyde, Polysorbate 80.
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B, Neomycin
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2 to 8C (35 to 46F). Do not freeze.
- Approved Age for Licensed Use: 2 months to six years of age.
- Description: Products: Proteins + killed virus. Other components: Bovine albumin Formaldehyde, Glutaraldehyde, Polysorbate 80.
|
| References |
|
|
|
Td Polio Adsorbed |
| Vaccine Information |
- Vaccine Name: Td Polio Adsorbed
- Tradename: Td Polio Adsorbed
- Manufacturer: Sanofi Pasteur Ltd
- Vaccine Ontology ID: VO_0011482
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- VO ID: VO_0000128
- Description: Td POLIO ADSORBED [Tetanus and Diphtheria Toxoids Adsorbed and Inactivated Poliomyelitis Vaccine]
produced by Sanofi Pasteur Limited, is a sterile, cloudy, white, uniform suspension of tetanus and diphtheria
toxoids adsorbed on aluminum phosphate and suspended in phosphate buffered saline solution and
combined with Inactivated Poliomyelitis Vaccine for intramuscular injection only.
Products: Proteins + killed virus. Other components: Bovine albumin Formaldehyde, Polysorbate 80.
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F).
- Approved Age for Licensed Use: 7 years and older.
- Description: Td POLIO ADSORBED [Tetanus and Diphtheria Toxoids Adsorbed and Inactivated Poliomyelitis Vaccine] produced by Sanofi Pasteur Limited, is a sterile, cloudy, white, uniform suspension of tetanus and diphtheria toxoids adsorbed on aluminum phosphate and suspended in phosphate buffered saline solution and combined with Inactivated Poliomyelitis Vaccine for intramuscular injection only. Products: Proteins + killed virus. Other components: Bovine albumin Formaldehyde, Polysorbate.
|
| References |
|
|
|
Td Polio Adsorbed |
| Vaccine Information |
- Vaccine Name: Td Polio Adsorbed
- Product Name: Tetanus and Diphtheria Toxoids Adsorbed and Inactivated Poliomyelitis Vaccine
- Tradename: Td Polio Adsorbed
- Manufacturer: Sanofi Pasteur Ltd
- Vaccine Ontology ID: VO_0011482
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F).
- Approved Age for Licensed Use: 7 years and older.
- Description: Td POLIO ADSORBED [Tetanus and Diphtheria Toxoids Adsorbed and Inactivated Poliomyelitis Vaccine]
produced by Sanofi Pasteur Limited, is a sterile, cloudy, white, uniform suspension of tetanus and diphtheria
toxoids adsorbed on aluminum phosphate and suspended in phosphate buffered saline solution and
combined with Inactivated Poliomyelitis Vaccine for intramuscular injection only.
Products: Proteins + killed virus. Other components: Bovine albumin Formaldehyde, Polysorbate 80.
|
| References |
|
|
|
